Professor of Pharmacology and of Molecular Biophysics and Biochemistry
Co-Director Therapeutics/Chemotherapy Program
Individuals infected with HIV have a substantially higher risk of developing cancer compared with uninfected people of the same age. The Anderson laboratory is involved in developing new antiviral therapies to treat HIV infections. A major focus is HIV reverse transcriptase, a viral polymerase essential for HIV replication.<_o3a_p />
Henry Bronson Professor of Pharmacology
Chairman, Consortium for the Globalization of Chinese Medicine (CGCM)
The Cheng laboratory studies the action of antiviral drugs against HBV, HIV, EBV, and HCV, as well as the discovery of antivirals with unique mode of action against those viruses.
Eugene Higgins Professor of Chemistry and Professor of Pharmacology
Jon was born and raised near Los Angeles and received his B.S. degree at MIT and his Ph.D. degree from Harvard University. He was a postdoctoral fellow at the University of California at Berkeley and subsequently joined the faculty at the same institution. Prior to coming to Yale University, he was Professor in the Department of Chemistry at UC Berkeley and jointly held a faculty position in the Department of Cellular and Molecular Pharmacology at UC San Francisco. He has published more than...
Ensign Professor of Medicine (Medical Oncology) and Professor of Pharmacology
Chief of Medical Oncology, Yale Cancer Center and Smilow Cancer Hospital
Associate Director for Translational Research, Yale Cancer Center
Disease Aligned Research Team (DART) Leader, Thoracic Oncology Program, Yale Cancer Center